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Abstract
Introduction:  Vestibular  migraine  (VM)  is  one  of  the  most  often  common  diagnoses  in  neurotol-
ogy, but  only  recently  has  been  recognized  as  a  disease.
Objective:  To  analyze  the  clinical  and  epidemiological  profile  of  patients  with  VM.
Methods: This  was  a  retrospective,  observational,  and  descriptive  study,  with  analysis  of
patients’ records  from  an  outpatient  VM  clinic.
Results:  94.1%  of  patients  were  females  and  5.9%  were  males.  The  mean  age  was  46.1  years;
65.6% of  patients  had  had  headache  for  a  longer  period  than  dizziness.  A  correlation  was
detected between  VM  symptoms  and  the  menstrual  period.  61.53%  of  patients  had  auditory
symptoms,  with  tinnitus  the  most  common,  although  tonal  audiometry  was  normal  in  68.51%.
Vectoelectronystagmography  was  normal  in  67.34%,  10.20%  had  hyporeflexia,  and  22.44%  had
vestibular  hyperreflexia.  Electrophysiological  assessment  showed  no  abnormalities  in  most
patients.  Fasting  plasma  glucose  and  glycemic  curve  were  normal  in  most  patients,  while  the
insulin curve  was  abnormal  in  75%.  82%  of  individuals  with  MV  showed  abnormalities  on  the
metabolism  of  carbohydrates.
Conclusion:  VM  affects  predominantly  middle-aged  women,  with  migraine  headache  represent-
ing the  first  symptom,  several  years  before  vertigo.  Physical,  auditory,  and  vestibular  evaluations
are usually  normal.  The  most  frequent  vestibular  abnormality  was  hyperreflexia.  Most  individ-
uals showed  abnormality  related  to  carbohydrate  metabolism.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
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Migrânea  vestibular:  aspectos  clínicos  e  epidemiológicos
Resumo
Introduc¸ão:  Migrânea  vestibular  (MV)  corresponde  a  um  dos  mais  frequentes  diagnósticos  em
otoneurologia,  o  que  justifica  a  importância  de  seu  estudo,  embora  tenha  sido  apenas  recente-
mente reconhecida  como  entidade  nosológica.
Objetivo:  Analisar  os  perfis  clínico  e  epidemiológico  dos  pacientes  atendidos  em  um  ambu-
latório de  migrânea  vestibular.
Método:  Estudo  retrospectivo,  observacional  e  descritivo,  com  análise  de  prontuários  dos
pacientes  do  ambulatório  de  MV.
Resultados:  O  ambulatório  é  composto  por  94,1%  de  mulheres  e  5,9%  de  homens,  com  média
de idade  46,1  anos.  O  tempo  de  cefaleia  foi  superior  ao  de  vertigem  em  65,6%  dos  pacientes.
Observou-se  correlac¸ão  entre  os  sintomas  e  o  período  menstrual.  A  maioria  (61,53%)  dos
indivíduos  apresentou  algum  sintoma  auditivo,  sendo  o  zumbido  o  mais  frequente,  emb-
ora a  audiometria  tenha  sido  normal  em  68,51%.  A  vectoeletronistagmografia  apresentou-se
normal  em  67,34%,  enquanto  10,20%  apresentaram  hiporreflexia  e  22,44%  hiperreflexia  vesti-
bular. Exames  eletrofisiológicos  não  mostraram  alterac¸ões  na  maioria  dos  pacientes.  Glicemia
de jejum  e  curva  glicêmica  foram  normais  para  a  maioria  dos  pacientes,  enquanto  a  curva
insulinêmica  mostrou-se  alterada  em  75%  dos  indivíduos.  82%  dos  indivíduos  com  MV  apresen-
taram alguma  alterac¸ão  relativa  ao  metabolismo  dos  carboidratos.
Conclusão:  Migrânea  vestibular  acomete,  predominantemente,  mulheres  de  meia  idade,  com
cefaleia  migranosa  e  vertigem,  sendo  a  primeira  de  instalac¸ão  mais  precoce.  O  exame  físico
no período  intercrise,  bem  como  as  avaliac¸ões  auditiva  e  vestibular,  mostram-se,  geralmente,
normais. O  tipo  de  alterac¸ão  vestibular  mais  observado  foi  a  hiperreflexia  labiríntica.  A  maioria
os indivíduos  avaliados  apresentou  alterac¸ões  relativas  ao  metabolismo  dos  carboidratos.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
ses/
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he  association  between  migraine  and  vestibular  symptoms
as  been  known  for  a  long  time,  and  became  more  evident
fter  a  systematic  study  carried  out  in  1984  by  Kyan  and
ood.1
Migraine  and  vertigo  are  common  clinical  conditions  that
ffect,  respectively,  14%  and  7%  of  the  general  population.
heir  simultaneous  occurrence  would  be  1%,  if  occurring
t  random.  However,  recent  epidemiological  studies  indi-
ate  that  3.2%  of  the  population  have  both  migraine  and
ertigo.2,3 This  can  be  attributed  to  two  factors:  vertigo
yndromes  (Meniere’s  disease,  benign  paroxysmal  positional
ertigo,  and  dizziness  related  to  anxiety),  which  are  more
ommon  in  migraineurs  when  compared  to  controls;  and
estibular  migraine  (VM).2--4
Vestibular  migraine  is  an  entity  first  described  in  1999
y  Dieterich  and  Brandt5 and  corresponds  to  a  variant
f  migraine  whose  main  symptoms  are  vestibular.  VM  is
ore  common  in  individuals  without  aura,  and  affects
redominantly  women,  at  a  frequency  of  up  to  5:1.4,6 Ves-
ibular  symptoms  typically  occur  several  years  after  the
isease  onset,  when  headache  may  be  less  frequent  or
ven  absent.2,4 The  onset  of  vestibular  symptoms  replac-
ng  the  headache  is  more  commonly  seen  in  perimenopausal
omen.7
The  temporal  association  between  migraine  symptoms
uch  as  headache,  photo  and  phonophobia,  and  the  vesti-
ular  symptoms  is  variable,  even  in  the  same  individual.6
M  episodes  can  be  triggered  by  the  same  factors  considered
T
sby/4.0/).
riggers  for  migraine  headache,  such  as  menstrual  period,
rregular  sleep,  stress,  physical  activity,  dehydration,  and
ertain  foods  and  drinks,  in  addition  to  intense  sensory
timulation.6,8
Diagnostic  criteria  for  VM  were  proposed  by  Neuhauser  in
0014 and  revised  in  2012  by  Bárány  Society,  together  with
he  International  Headache  Society,  which  included  it  in  an
ppendix  in  2013,  of  the  third  edition  of  the  International
lassification  of  Headaches,  as  a  first  step  to  identifying  new
ntities  (Figure  1).9,10
The  physical  examination  of  patients  with  vestibular
igraine  is  usually  normal  between  crises.  During  disease
pisodes,  however,  there  is  often  spontaneous  or  positional
ystagmus,  with  characteristics  of  peripheral  or  central
nvolvement.6,11 Vectoelectronystagmography  is  generally
ormal,  with  unilateral  labyrinthine  hypofunction  reported
n  up  to  20%  of  cases.6,12 Hearing  assessment,  likewise,  is
ormal  in  most  patients.6 Due  to  labyrinthine  alterations,  it
s  necessary  to  exclude  other  otoneurological  diagnoses.
The  aim  of  this  study  was  to  analyze  the  clinical  and
pidemiological  profile  of  patients  treated  in  the  vestibular
igraine  outpatient  clinic  of  the  Otoneurology  Service  of
he  Discipline  of  Otology  and  Neurotology  of  the  Depart-
ent  of  Otorhinolaryngology  and  Head  and  Neck  Surgery,
niversidade  Federal  de  São  Paulo  (UNIFESP).
ethodshis  was  a  cross-sectional,  observational,  and  descriptive
tudy,  carried  out  at  the  vestibular  migraine  outpatient
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1. Vestibular migraine
2. Probable vestibular migraine
A. At  lea st  5 ep isod es with vestibu lar sy mptoms of mode rate or severe 
intensity, lasting 5 min to 72 hours. 
B. Current or previous history of migraine with or without aura 
according to the  Interna tiona l Cl ass ification  of  Head ache  Di sorders 
(ICHD)9
C. One  or more migraine features wi th at  lea st  50% of the  vestibu lar 
episodes:  
o headache with at least two of the following characteristics: 
one sided location, pulsating quality, moderate or severe pain 
intensity, aggravation by routine physical activity  
o photophobia and phonophobia,  
o visual aura 
D. Not  bett er accoun ted for by an othe r vestibu lar or ICHD diagno sis9
A. At least 5 episodes with vestibular symptoms of moderate or severe 
intensit y, lasting 5 min to 72 hours   
B. Only one of the criteria B and C for vestibular migraine 
C. Not  bett er accoun ted for by an othe r vestibu lar or ICHD diagno sis9
Figure  1  Diagnostic  criteria.
Lempert  T,  Olesen  J,  Furman  J,  Waterston,  Seemungal  B,  Carey
J, et  al.  Vestibular  migraine:  Diagnostic  criteria  Consensus  doc-
Table  1  General  aspects  of  symptoms  in  patients  with  ves-
tibular  migraine.
n  %  p-Value
Concomitant  occurrence  of  dizziness  and  headache
symptoms
Yes  48  67.6  <0.001
Sometimes  13  18.3
No 10  14.1
Distribution  of  vertigo  frequency  in  patients  with
vestibular  migraine
Daily  17  22.1
Daily  to  weekly 35  45.5
Weekly  to  monthly 13  16.9 <0.003
<1×/month  12  15.6
Correlation  between  migraine  and  menstrual  period  in
patients  with  vestibular  migraine
Yes  25  80.6  <0.001
No 6  19.4
Correlation  between  vertigo  and  menstrual  period  in
patients  with  vestibular  migraine
Yes 11  61.1  >0.005
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The  cervical  vestibular-evoked  myogenic  potential
(VEMP)  was  assessed  in  17  patients,  and  alterations  were
observed  in  three  (17.6%)  (Table  5).
Table  2  Distribution  of  auditory  symptoms  in  patients  with
vestibular  migraine.
Complaint  n  %
Hearing  loss  14  17.94
Tinnitus  41  52.56ument of  the  Bárány  Society  and  the  International  Headache
Society.  Rev  Neurol  (Paris).  2014;170:401--6.
clinic  of  the  Discipline  of  Otology  and  Neurotology  of
the  Department  of  Otorhinolaryngology  and  Head  and
Neck  Surgery  of  Universidade  Federal  de  São  Paulo
(UNIFESP).
Patient  records  were  selected  from  the  VM  outpatient
clinic,  since  its  creation  in  February  of  2011  to  June  of
2013.
Patients  were  analyzed  according  to  epidemiological
data,  such  as  gender,  age,  profession,  and  nationality,  in
addition  to  the  clinical  characteristics  of  the  disease,  previ-
ous  medical  history,  and  laboratory,  auditory,  and  vestibular
test  results.  This  study  was  approved  by  the  Research
Ethics  Committee  of  the  Universidade  Federal  de  São  Paulo
(UNIFESP)  (No.  19615313.13.5.0000.5505).
Statistical  tests  were  selected  according  to  the  data  pro-
file:  the  Kruskal--Wallis  test  was  used  to  compare  more  than
two  variables,  simultaneously;  the  Mann--Whitney  test  was
used  to  compare  variables  in  pairs;  and  the  two-sample  test
for  equality  of  proportions  was  used  to  assess  whether  the
proportion  of  answers  of  two  variables  or  levels  was  signifi-
cant.
The  95%  confidence  intervals  (95%  CI)  and  p  <  0.05  were
accepted  for  all  analyses.  SPSS  v.  17,  Minitab  v.  16,  and  Excel
Office  2010  were  used  for  the  statistical  analysis.
Results
Of  the  total  of  85  patients,  80  (94.1%)  were  women  and  five
(5.9%)  were  men,  with  ages  ranging  from  19  to  79  years  --  a
mean  of  46.1  years  and  a  median  of  47  years.
The  time  until  symptom  onset  is  shown  in  Figure  1.  The
symptom  of  headache  appeared,  on  average,  7.3  years  ear-
lier  when  compared  to  dizziness.  It  was  also  observed  that
65.6%  of  patients  had  had  headaches  for  a  longer  period
when  compared  to  vertigo.
It  was  observed  that  headaches  and  dizziness  occurred
concomitantly  in  most  patients,  as  shown  in  Table  1.No 7  38.9
Most  patients  experienced  episodes  of  dizziness  more
ften  than  once  a  week  (Table  1).
Headache  worsening  during  the  menstrual  period  was
eported  by  most  female  patients.  The  same  could  be
bserved  in  relation  to  dizziness,  although  it  was  not  sta-
istically  significant  (Table  1).
Forty-eight  of  78  patients  (61.53%)  reported  some  audi-
ory  symptoms,  and  some  reported  more  than  one  symptom
Table  2).
Fifty-four  patients  underwent  tonal  audiometry,  which
as  normal  in  37  (68.51%)  individuals.  Sensorineural  hearing
oss  was  the  most  frequently  observed  alteration  (Table  3).
Vectoelectronystagmography  was  performed  in  49
atients  and  was  normal  in  most  individuals.  Among  the
hanges,  vestibular  hyperreflexia  was  the  most  frequent,
s  shown  in  Table  4.
The  brainstem  evoked  response  audiometry  (BERA)  was
hown  to  be  altered  in  two  (10.5%)  of  19  patients  who  under-
ent  the  examination.  In  both,  the  alteration  consisted  of
n  increase  in  the  electrophysiological  threshold.Ear fullness  23  29.48
No complaint 30  38.46
Total 78  100
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Table  3  Pure  tone  audiometry  findings  in  patients  with  vestibular  migraine.
Type  of  finding  n  %  Right  unilateral  Left  unilateral  Bilateral
n  %  n  %  n  %
CHL  1  1.85  1  1.85  0  0  0  0
MHL 3  5.55  0  0  2  8.33  1  1.85
SHL 13  24.07  0  0  2  8.33  11  20.37
Normal 37  68.51
Total 54  100
CHL, conductive hearing loss; MHL, mixed hearing loss; SHL, sensorineural hearing loss.
Table  4  Vectoelectronystagmography  findings  in  patients  with  vestibular  migraine.
Type  of  finding  n  %  Right  unilateral  Left  unilateral  Bilateral
n  %  n  %  n  %
Hyporeflexia  5  10.20  1  2.04  1  2.04  3  6.12
Hyperreflexia  11  22.44  2  4.08  3  6.12  6  12.24
Central 0  0  0  0  0  0  0  0
Normal 33  67.34
Total  49  100
Of  81  patients,  49  (60.4%)  had  some  comorbidity,  among
which  systemic  arterial  hypertension  (SAH)  was  the  most
prevalent  (Table  6).  Four  records  lacked  this  information.
Regarding  the  metabolic  evaluation,  glucose  and  insulin
curves  were  requested  for  all  individuals  without  a  diagnosis
of  diabetes  mellitus.  For  those  known  to  be  diabetics,  fasting
glucose  measurement  was  requested.
Information  on  fasting  glucose  of  57  patients,  with  and
without  diabetes,  was  obtained.  Of  these,  71.92%  showed
normal  and  28.08%  had  altered  values  (p  <  0.001).  Values
between  100  and  125  mg/dL  (impaired  glucose  tolerance)
were  observed  in  21.75%,  while  7.01%  had  fasting  blood  glu-
cose  greater  than  125  mg/dL  (diabetes  mellitus).13
Fifty-three  patients,  all  without  a  prior  diagnosis  of  dia-
betes  mellitus,  underwent  the  test  after  intake  of  75  g
of  dextrose.  After  120  min,  77.4%  of  the  subjects  had
normal  blood  glucose  levels  (<140  mg/dL  and  >55  mg/dL);
22.6%  had  altered  results  (p  <  0.001)  --  11.32%  (n  =  6)  show-
ing  decreased  glucose  tolerance  (140--199  mg/dL)  and  5.6%
(n  =  3)  individuals  had  diabetes  mellitus  (blood  glucose  above
200  mg/dL).13 Three  individuals  (5.6%)  had  glucose  levels
<55  mg/dL  (hypoglycemia)  at  120  min.13
Insulin  curve  was  assessed  in  43  patients,  also  without  a
diagnosis  of  diabetes  mellitus.  Of  these,  74.5%  had  abnormal
Table  5  Distribution  of  cervical  vestibular-evoked  myo-
genic potential  results  in  patients  with  vestibular  migraine.
Cervical  VEMP  n  %
Increased  latency  0  0
Altered  asymmetry  index  3  17.64
Normal  14  82.35
Total  17  100
VEMP, vestibular-evoked myogenic potential.
Table  6  Distribution  of  comorbidities  in  patients  with  ves-
tibular  migraine.
Comorbidity  n  %
SAH  26  32.09
Others  26  32.09
Dyslipidemia  16  19.75
Depression  10  12.34
Diabetes  mellitus  6  7.40
Hypothyroidism  6  7.40
Epilepsy  3  3.70
No comorbidities  32  39.5
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pTotal  81  100
SAH, systemic arterial hypertension.
alues,  whereas  25.5%  had  normal  results  (p  <  0.001),
ccording  to  the  Kraft  criteria.14,15 Hypoinsulinism  (insulin
50  U/mL  in  all  measurements)  was  observed  in  17  (39.5%)
ndividuals.  The  sum  of  the  values  at  120  and  180  min  was
reater  than  60  U/mL  in  seven  (16.27%)  patients  (Kraft
ype  II  curve).  The  means  of  these  values  were,  respectively,
4.3  U/mL  and  23.4  U/mL.14,15 Eight  tests  showed  delayed
nsulin  peak,  at  120  or  180  min  (Kraft  type  III  curve).14,15
In  total,  82.22%  of  the  patients  had  some  carbohydrate
etabolism  alteration,  considering  diabetes,  hypoglycemia,
ecreased  glucose  tolerance,  hypoinsulinism  and  occult  dia-
etes,  according  to  Kraft’s  criteria.
The  mean  values  for  glucose,  insulin,  hemoglobin,  lipids,
nd  creatinine  are  found  in  Table  7.iscussion
his  cross-sectional  study  assessed  the  characteristics  of
atients  with  vestibular  migraine.  There  was  a  higher
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Table  7  Metabolic  assessment  of  patients  with  vestibular  migraine.
Laboratory  Mean  Median  CV  (%)  Min  Max  n  CI
Hb  13.6 13.6  7  11.7  16.5  57  0.2
LDL 109.9  111  33  39.2  195  57  9.4
HDL 53.7  55  29  31  110  57  4.1
Triglycerides  121.7  107  52  32  309  57  16.5
Fasting blood  glucose  94.9  90  16  75  149  57  4.0
30′ 143.0  134  29  76  289  48  11.8
60′ 130.2  117  41  65  298  47  15.2
90′ 112.7  101  49  58  356  47  15.6
120′ 114.9 100  50  53  371  49  16.0
180′ 83.8 78  50  36  312  45  12.3
Glycated Hb 6.6 6.05 27  5.6 11.1 8  1.3
Fasting insulin  7.7  4.9  111  0.27  40.7  46  2.5
30′ 63.3  50.4  98  2.6  403.3  44  18.2
60′ 62.7  46.07  85  2.2  244.8  45  15.6
90′ 59.2  37.1  103  1.13  246.8  44  17.9
120′ 64.3  34.95  104  4.25  341.0  44  19.8
180′ 23.4  11.08  127  2.16  156.6  43  8.8
Creatinine 0.71  0.71  24  0  1.01  38  0.05
Hb, hemoglobin; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
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Cprevalence  among  women,  mainly  between  the  fifth  and
sixth  decade  of  life  (mean  46.1  years),  corroborating  liter-
ature  data.2--4,6 The  later  onset  of  vertigo  symptoms,  when
compared  to  headache,  was  also  confirmed.2,3,6
Dizziness  appeared,  on  average,  seven  years  after  the
pain  onset.  The  worsening  of  headache  during  the  menstrual
period,  well  known  among  women  diagnosed  with  migraine
(50--60%  of  the  cases),  was  also  observed  in  the  present
sample.16,17 The  same  occurred  with  the  correlation  dizzi-
ness  vs.  menstrual  period.  However,  for  the  latter,  there
was  no  statistical  correlation,  which  may  be  due  to  the  small
sample  size,  or  due  to  the  onset  of  vertigo  after  menopause
in  many  patients.6
Most  patients  reported  concomitant  occurrence  of
headache  and  vertigo,  and  isolated  symptoms  occurred  in
14%.  In  these  cases,  migraine  equivalents  such  as  photo  and
phonophobia  or  aura  must  accompany  vestibular  episodes
in  at  least  50%  of  the  episodes  in  order  to  characterize
VM.  Otherwise,  it  can  be  defined  as  probable  vestibular
migraine.4,9,10 It  was  found  that  77%  of  the  individuals
reported  episodes  of  VM  more  than  once  per  week.
Auditory  symptoms  were  observed  in  61.53%  of  the  sub-
jects,  with  the  tinnitus  representing  the  main  complaint.
However,  the  auditory  assessment  by  pure  tone  audiome-
try  was  unaltered  in  68.51%  of  patients.  Hearing  loss,  when
present,  was  predominantly  sensorineural,  bilateral,  sym-
metric,  descending,  and  mild.  Similar  findings  were  reported
by  Radtke  et  al.,  who  attributed  to  VM  a  much  slower  hearing
loss  when  compared  to  that  observed  in  Meniere’s  disease.18
Vestibular  assessment  through  vectoelectronystagmog-
raphy  was,  in  most  cases,  normal,  in  accordance  with
literature  findings.6,18 The  most  frequently  observed  alter-
ation,  however,  was  bilateral  vestibular  hyperreflexia,
followed  by  unilateral  hyperreflexia.  Some  authors  have
mentioned  unilateral  labyrinthine  hypofunction  as  the  most
frequent  alteration.6,18 Radtke  et  al.  found  16%  unilateral
V
w
wypofunction,  4%  bilateral  hyporreflexia,  and  the  same  value
or  bilateral  hyperreflexia  after  a  follow  up  of  nine  years.18
Regarding  the  electrophysiological  assessment,  both  the
ERA  and  VEMP  were  normal  in  most  individuals.
A  higher  prevalence  of  hypothyroidism  was  found  in
his  sample  (7.4%)  when  compared  to  the  Brazilian  gen-
ral  population  (1.5%)19 (p  < 0.001).  For  all  other  assessed
omorbidities  --  hypertension,  dyslipidemia,  depression,
iabetes,  and  epilepsy  --  there  were  no  statistically  signifi-
ant  differences.20--22
Most  VM  patients  had  normal  fasting  glucose,  as  well
s  normal  values  at  120  min  after  administration  of  75  g  of
extrose.13 However,  the  insulin  curve  showed  an  alteration
n  75%  of  subjects.14,15
VM  has  been  only  recently  described,  and  its  diagnosis
s  purely  clinical.  The  presence  of  symptoms  that  are
ommon  to  other  neurotological  diseases,  associated  with
he  absence  of  an  objective  test,  makes  its  diagnosis
hallenging.
Alterations  in  glycemic  and/or  insulinemic  curves  of
ndividuals  without  a specific  diagnosis  can  lead  to  overes-
imation  of  metabolic  alterations  as  the  primary  cause  of
estibular  dysfunction.  The  error  can  also  be  supported  by
he  good  response  of  the  individual  to  clinical  treatment,
hich  includes  dietary  recommendations  and  the  practice  of
hysical  activities.  It  is  known,  however,  that  such  measures
re  part  of  the  first  line  of  the  prophylactic  treatment  of
estibular  migraine,  which  could  explain  symptom  improve-
ent  in  patients  who  receive  this  kind  of  recommendation.
onclusionestibular  migraine  affects  predominantly  middle-aged
omen  with  a  history  of  migraine  headache  and  vertigo,
ith  the  first  showing  an  earlier  onset.  Physical  examination
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202  
n  the  period  between  crises,  as  well  as  auditory  and  ves-
ibular  assessments,  are  usually  normal.  The  most  frequent
estibular  alteration  was  labyrinthine  hyperreflexia.  Most
f  the  assessed  individuals  had  carbohydrate  metabolism
lteration.
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